Release Date: 08/07/19 09:15 Summary: Volpara signs agreement to sell ScreenPoint Medical's CAD Price Sensitive: Yes Download Document 163.27KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%